Overview
This page focuses on how to think about basic dose and exposure concepts in an abstract way for BPC-157 + GHK-CU + TB-500 + KPV and similar peptides. It does not provide dosing instructions or protocols.
Key themes in dosing concepts
- Understanding vial amount, dilution volume, and resulting concentration.
- Relating concentration to an abstract "unit" or hypothetical dose.
- Recognizing that pharmacokinetics (absorption, distribution, metabolism, elimination) influence exposure beyond simple vial math.
Context and caveats
Any concrete dosing decisions for BPC-157 + GHK-CU + TB-500 + KPV must be grounded in product labelling (where it exists), formal clinical guidance, and individualized medical judgment. Educational tools such as calculators and half-life plotters are best treated as aids for understanding, not as dosing engines.
Sport & Anti-Doping Warning
This four-way blend layers KPV and GHK-Cu on top of BPC-157 and TB-500. From an anti-doping perspective, the inclusion of BPC-157/TB-500 is enough to make it clearly prohibited.
Stacking additional experimental peptides on top of already-prohibited agents increases uncertainty and does not mitigate anti-doping risk.